HURA · TuHURA Biosciences, Inc./NV

NasdaqHealthcareBiotechnology

Tuhura Biosciences Inc Is A Phase 3 Clinical Stage Immuno-Oncology Company With Three Distinct Technologies Focused On The Development Of Novel Therapeutics Designed To Overcome Primary And Acquired Resistance To Cancer Immunotherapies. The Company'S Personalized Cancer Vaccine Candidate, Ifx-2.0, Is Designed To Overcome Primary Resistance To Checkpoint Inhibitors. The Company Operates In One Reportable Segment, Which Includes All Activities Related To Advancing Therapies For Cancer Treatment.

HealthcareNasdaqUSMid Float

FLOAT

44.4M

FREE FLOAT %

70%

SHARES O/S

63.7M

MARKET CAP

$138.9M

EXCHANGE

Nasdaq

COUNTRY

HURA Catalyst History

No catalysts recorded for HURA yet

Day Trader Sniper hasn't classified a publishable catalyst for HURA yet. New events appear here as they're scored.

Be early on the next HURA spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

HURA · TuHURA Biosciences, Inc./NV

HURA Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.